Oligoreview of Non-Small Cell Lung Cancer Oligometastases

Meredith E. Giuliani; Clifford G. Robinson; Joseph K. Salama; Megan E. Daly

doi:10.1016/j.ijrobp.2019.11.009

Oligoreview of Non-Small Cell Lung Cancer Oligometastases

Meredith E. Giuliani, Clifford G. Robinson, Joseph K. Salama, Megan E. Daly

Research output: Contribution to journal › Review article › peer-review

Original language	English
Pages (from-to)	455-459
Number of pages	5
Journal	International Journal of Radiation Oncology Biology Physics
Volume	106
Issue number	3
DOIs	https://doi.org/10.1016/j.ijrobp.2019.11.009
State	Published - Mar 1 2020

Access to Document

10.1016/j.ijrobp.2019.11.009

Cite this

@article{a10f486a0ab14594a79a0b6a05b76190,

title = "Oligoreview of Non-Small Cell Lung Cancer Oligometastases",

author = "Giuliani, {Meredith E.} and Robinson, {Clifford G.} and Salama, {Joseph K.} and Daly, {Megan E.}",

note = "Funding Information: Disclosures: M.G. reports funding from Elekta, AstraZeneca, Bristol-Myers Squibb, and Eli Lilly. C.R. reports research funding from Elekta, Varian Medical Systems, and Merck; consulting for AstraZeneca, EMD Serono, and Radialogica; and equity from Radialogica. J.K.S. reports funding from AbbVie, Merck, Array, and Bristol-Myers Squibb. M.E.D. reports research funding from EMD Serono and Genentech and consulting for Boston Scientific and Triptych Health Partners. ",

year = "2020",

month = mar,

day = "1",

doi = "10.1016/j.ijrobp.2019.11.009",

language = "English",

volume = "106",

pages = "455--459",

journal = "International Journal of Radiation Oncology Biology Physics",

issn = "0360-3016",

number = "3",

}

TY - JOUR

T1 - Oligoreview of Non-Small Cell Lung Cancer Oligometastases

AU - Giuliani, Meredith E.

AU - Robinson, Clifford G.

AU - Salama, Joseph K.

AU - Daly, Megan E.

N1 - Funding Information: Disclosures: M.G. reports funding from Elekta, AstraZeneca, Bristol-Myers Squibb, and Eli Lilly. C.R. reports research funding from Elekta, Varian Medical Systems, and Merck; consulting for AstraZeneca, EMD Serono, and Radialogica; and equity from Radialogica. J.K.S. reports funding from AbbVie, Merck, Array, and Bristol-Myers Squibb. M.E.D. reports research funding from EMD Serono and Genentech and consulting for Boston Scientific and Triptych Health Partners.

PY - 2020/3/1

Y1 - 2020/3/1

UR - http://www.scopus.com/inward/record.url?scp=85078871041&partnerID=8YFLogxK

U2 - 10.1016/j.ijrobp.2019.11.009

DO - 10.1016/j.ijrobp.2019.11.009

M3 - Review article

C2 - 32014142

AN - SCOPUS:85078871041

SN - 0360-3016

VL - 106

SP - 455

EP - 459

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

IS - 3

ER -

Oligoreview of Non-Small Cell Lung Cancer Oligometastases

Access to Document

Other files and links

Cite this